Structural Studies of Cancer Proteins

Lead researcher

Dr Mark Hinds, Dr Catherine Day

Walter & Eliza Hall Institute of Medical Research

Years funded

Over-production of pro-survival Bcl-2 proteins is not only a molecular mechanism behind many cancers but confers resistance to treatment by preventing their natural programmed death.

We will explore the molecular structures of the Bcl-2 proteins and anticipate designing drugs that directly inhibit pro-survival Bcl-2 proteins letting loose the natural cell death processes to kill cancer cells selectively.

Funding Body

Cancer Council Research Grant


$100,000 per annum